CLINICAL_TRIALS
trial_result
· 2017-05-30
Clinical Trial Update: Double-Blind Treatment of Major Depressive Disorder With Vilazodone [Phase 2]
Summary
Phase 2 double-blind trial evaluating vilazodone for major depressive disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30